David C. James

9.8k total citations · 2 hit papers
127 papers, 7.3k citations indexed

About

David C. James is a scholar working on Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David C. James has authored 127 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 24 papers in Genetics and 23 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David C. James's work include Viral Infectious Diseases and Gene Expression in Insects (57 papers), Virus-based gene therapy research (23 papers) and Monoclonal and Polyclonal Antibodies Research (22 papers). David C. James is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (57 papers), Virus-based gene therapy research (23 papers) and Monoclonal and Polyclonal Antibodies Research (22 papers). David C. James collaborates with scholars based in United Kingdom, Australia and United States. David C. James's co-authors include D. A. Brewerton, Anne Nicholls, F. Dudley Hart, R D Sturrock, D. Walters, Nigel Jenkins, Diane M. Dinnis, Andrew J. Racher, Raj Parekh and Yuan Zheng and has published in prestigious journals such as Nature, The Lancet and Nucleic Acids Research.

In The Last Decade

David C. James

127 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ANKYLOSING SPONDYLITIS AND HL-A 27

1973 1.4k citations David C. James et al. profile →
ACUTE ANTERIOR UVEITIS AND HL-A 27

1973 319 citations David C. James et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David C. James United Kingdom	41	3.9k	2.1k	1.7k	1.3k	1.2k	127	7.3k
Tatsuji Yasuda Japan	38	2.7k 0.7×	1.1k 0.5×	1.7k 1.0×	806 0.6×	460 0.4×	174	5.5k
William J. Koopman United States	47	1.8k 0.5×	2.4k 1.1×	3.8k 2.2×	2.1k 1.5×	455 0.4×	178	8.0k
Bernard J. Scallon United States	28	1.3k 0.3×	633 0.3×	1.5k 0.8×	1.0k 0.8×	674 0.6×	38	3.9k
Amy S. Rosenberg United States	35	2.5k 0.6×	733 0.3×	1.6k 0.9×	1.3k 0.9×	362 0.3×	84	5.5k
Ger J.M. Pruijn Netherlands	56	6.1k 1.6×	3.0k 1.4×	2.7k 1.6×	2.1k 1.5×	804 0.7×	189	11.3k
Thomas Winkler Germany	55	3.4k 0.9×	1.1k 0.5×	4.6k 2.7×	1.1k 0.8×	829 0.7×	210	10.0k
Peter A. Kiener United States	59	3.8k 1.0×	970 0.5×	4.4k 2.5×	1.7k 1.3×	410 0.3×	124	10.6k
Mark J. Mamula United States	40	1.2k 0.3×	1.2k 0.6×	3.5k 2.0×	985 0.7×	720 0.6×	86	5.8k
Ralph B. Arlinghaus United States	51	5.4k 1.4×	1.3k 0.6×	1.1k 0.7×	585 0.4×	1.3k 1.1×	250	10.7k
P. J. Lachmann United Kingdom	50	1.6k 0.4×	922 0.4×	4.6k 2.6×	1.2k 0.9×	630 0.5×	201	8.0k

Countries citing papers authored by David C. James

Since Specialization

Citations

This map shows the geographic impact of David C. James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. James more than expected).

Fields of papers citing papers by David C. James

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. James. The network helps show where David C. James may publish in the future.

Co-authorship network of co-authors of David C. James

This figure shows the co-authorship network connecting the top 25 collaborators of David C. James. A scholar is included among the top collaborators of David C. James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. James. David C. James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Ping, et al.. (2024). Molecular design of controllable recombinant adeno‐associated virus (AAV) expression systems for enhanced vector production. Biotechnology Journal. 19(6). e2300685–e2300685. 5 indexed citations

Harris, Claire, Rebecca E. Williams, Olalekan Daramola, et al.. (2023). CHO synthetic promoters improve expression and product quality of biotherapeutic proteins. Biotechnology Progress. 39(5). e3348–e3348. 2 indexed citations

Cartwright, Joseph A., et al.. (2023). Directed evolution of biomass intensive CHO cells by adaptation to sub-physiological temperature. Metabolic Engineering. 81. 53–69. 2 indexed citations

Liu, Ping, et al.. (2022). Engineering of the CMV promoter for controlled expression of recombinant genes in HEK293 cells. Biotechnology Journal. 17(8). e2200062–e2200062. 16 indexed citations

Ross, Paul J., Harpreet Wasan, Daniel Croagh, et al.. (2021). Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy. ESMO Open. 7(1). 100356–100356. 13 indexed citations

Mercer, Andrew C., et al.. (2021). Design of synthetic promoters for controlled expression of therapeutic genes in retinal pigment epithelial cells. Biotechnology and Bioengineering. 118(5). 2001–2015. 14 indexed citations

Maisuria, Sheetal, Adam Brown, Kang Lan Tee, et al.. (2020). Production of trimeric SARS‐CoV‐2 spike protein by CHO cells for serological COVID‐19 testing. Biotechnology and Bioengineering. 118(2). 1013–1021. 23 indexed citations

Coss, Karen P., et al.. (2020). Cell function profiling to assess clone stability. Biotechnology and Bioengineering. 117(7). 2295–2299. 4 indexed citations

Brown, Adam, Christina Alves, Yizhou Zhou, et al.. (2019). CHO genome mining for synthetic promoter design. Journal of Biotechnology. 294. 1–13. 14 indexed citations

10.

Brown, Adam, et al.. (2018). Whole synthetic pathway engineering of recombinant protein production. Biotechnology and Bioengineering. 116(2). 375–387. 19 indexed citations

11.

Hatton, Diane, et al.. (2018). Control of amino acid transport into Chinese hamster ovary cells. Biotechnology and Bioengineering. 115(12). 2908–2929. 12 indexed citations

12.

Brown, Adam & David C. James. (2015). Precision control of recombinant gene transcription for CHO cell synthetic biology. Biotechnology Advances. 34(5). 492–503. 25 indexed citations

13.

Davies, Sarah L., et al.. (2012). Functional heterogeneity and heritability in CHO cell populations. Biotechnology and Bioengineering. 110(1). 260–274. 78 indexed citations

14.

O’Callaghan, Peter M., et al.. (2010). Cell line‐specific control of recombinant monoclonal antibody production by CHO cells. Biotechnology and Bioengineering. 106(6). 938–951. 88 indexed citations

15.

Smales, C. Mark, et al.. (2007). Transient Gene Expression Levels from Multigene Expression Vectors. Biotechnology Progress. 23(2). 435–443. 23 indexed citations

16.

Smales, C. Mark & David C. James. (2005). Therapeutic proteins : methods and protocols. Humana Press eBooks. 67 indexed citations

17.

Willingham, Mark C., Giulia Caron, David C. James, C. Mark Smales, & Gary K. Robinson. (2005). Monitoring changes in nisin susceptibility of Listeria monocytogenes Scott A as an indicator of growth phase using FACS. Journal of Microbiological Methods. 66(1). 43–55. 12 indexed citations

18.

Willingham, Mark C., David C. James, Gary K. Robinson, & C. Mark Smales. (2004). Global changes in gene expression observed at the transition from growth to stationary phase in Listeria monocytogenes ScottA batch culture. PROTEOMICS. 4(1). 123–135. 11 indexed citations

19.

Tait, Andrew S., et al.. (2004). Transient production of recombinant proteins by Chinese hamster ovary cells using polyethyleneimine/DNA complexes in combination with microtubule disrupting anti‐mitotic agents. Biotechnology and Bioengineering. 88(6). 707–721. 71 indexed citations

20.

Patel, Ashvin, et al.. (2002). Rapid monitoring of recombinant protein products: a comparison of current technologies. Trends in biotechnology. 20(4). 149–156. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact